CONTENTS:
- Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy. Bird K., Socias M.E., Ti L., p. 1-2.
- Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study. Roux P., Mezaache S., Briand-Madrid L., Debrus M., Khatmi N., Maradan G., et al., p. 3-9.
- Compulsory treatment of drug use in Southeast Asian countries. Lunze K., Lermet O., Andreeva V., Hariga F., p. 10-15.
- Developing a patient-reported experience questionnaire with and for people who use drugs: A community engagement process in Vancouver's Downtown Eastside. Olding M., Hayashi K., Pearce L., Bingham B., Buchholz M., Gregg D., et al., p. 16-23.
- Tuberculosis infection among cocaine crack users in Brazil. do Valle Leone de Oliveira S.M., Ferreira da Silva E., Coimbra Motta-Castro A.R., de Oliveira Landgraf de Castro V., Stábile A.C., Mello Miranda Paniago A., et al., p. 24-27.
- Grievable lives? Death by opioid overdose in Australian newspaper coverage. Fraser S., Farrugia A., Dwyer R., p. 28-35.
- Transitions in income generation among marginalized people who use drugs: A qualitative study on recycling and vulnerability to violence. Boyd J., Richardson L., Anderson S., Kerr T., Small W., McNeil R., p. 36-43.
- Stigma and the public health agenda for the opioid crisis in America. Corrigan P.W., Nieweglowski K., p. 44-49.
- Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy. Pontali E., Fiore V., Ialungo A.M., Ranieri R., Mollaretti O., Barbarini G., et al., p. 50-53.
- Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study. Derks L., Gassowski M., Nielsen S., an der Heiden M., Bannert N., Bock C.-T., et al., p. 54-62.
- Over and under-regulation in the Colorado Cannabis industry - A data-analytic perspective. Yates D., Speer J., p. 63-66.
- Cannabis decriminalization: A study of recent policy change in five U.S. states. Grucza R.A., Vuolo M., Krauss M.J., Plunk A.D., Agrawal A., Chaloupka F.J., et al., p. 67-75.
- Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada. Nouch S., Gallagher L., Erickson M., Elbaharia R., Zhang W., Wang L., et al., p. 76-84.
- Perceived harms and harm reduction strategies among people who drink non-beverage alcohol: Community-based qualitative research in Vancouver, Canada. Crabtree A., Latham N., Morgan R., Pauly B., Bungay V., Buxton J.A., p. 85-93.
- Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade. Tobin K., Clyde C., Davey-Rothwell M., Latkin C., p. 94-97.
- RETRACTED: The impact of medically supervised injection centres on drug-related harms: A meta-analysis. May T., Bennett T., Holloway K., p. 98-107.